Table 1.
Brazilian cohort – clinical characteristics of participants by CAD status
| With CAD | Without CAD | p | |
|---|---|---|---|
| Subjects (n) |
406 |
188 |
|
| Sex: Male (%) |
63 |
50 |
0.0005 |
| Age (y) |
60 ± 11 |
57 ± 11 |
0.0001 |
| Diabetes mellitus (%) |
48 |
52 |
0.35 |
| Fasting plasma glucose (mmol/l) |
7 ± 2.78 |
6.39 ± 1.89 |
0.03 |
| HbA1c (%) |
6.8 ± 1.6 |
6.6 ± 1.5 |
0.11 |
| BMI (kg/m2) |
27.1 ± 4.6 |
28.0 ± 5.0 |
0.06 |
| Dyslipidemia (%) |
95 |
86 |
0.01 |
| Triglycerides (mmol/l)* |
1.47[1.00-1.95] |
1.36[0.89-1.84] |
0.0002 |
| LDL Cholesterol (mmol/l) |
2.59 ± 0.93 |
2.67 ± 0.88 |
0.40 |
| HDL Cholesterol (mmol/l) |
0.98 ± 0.28 |
1.09 ± 0.28 |
0.0001 |
| eGFR(ml/min) |
84 ± 24 |
89 ± 28 |
0.05 |
| Hypertension (%) |
91 |
90 |
0.51 |
| Systolic BP (mmHg) |
140 ± 24 |
136 ± 20 |
0.09 |
| Diastolic BP (mmHg) |
80 ± 14 |
79 ± 13 |
0.54 |
| Tobacco smoking (%) | 57 | 42 | 0.003 |
Data expressed in mean ± SD, except *expressed in median [interquartile range]. CAD coronary artery disease, HbA1c glycated hemoglobin, eGFR estimated glomerular filtration rate. Differences between groups were assessed by Pearson’s chi squared test and ANOVA.